Bausch + Lomb BL5277Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 30757770058809), received between Sep 28, 2018 and Sep 28, 2018 — classified as 1 injury.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjurySep 28, 2018Break; Break

  DURING A POSTERIOR VITRECTOMY VIA PARS PLANA AND PHACOFRAGMENTATION A PIECE FROM THE STERILE TIP DETACHED AND REMAINED IN THE VITREOUS CAVITY (IN CONTACT WITH THE RETINA). AS A MEASURE TO CORRECT IT, THE PHACOFRAGMENTATION WAS SUSPENDED AND BOTH THE CATARACT AND THE METAL PIECE, WERE REMOVED. AFTER THE REMOVAL PATIENT EXPERIENCED RETINAL EDEMA AND PERSISTENCE OF MATERIAL SIMILAR TO FILAMENTS IN POSTERIOR AND CONJUNCTIVA CAVITY. THE CORNEAL EDEMA MADE IT DIFFICULT TO PERFORM A POSTERIOR EVALUATION. ON (B)(6) ADDITIONAL INFORMATION WAS RECEIVED STATING THAT OPHTHALMOLOGIST PRESCRIBED ZYPRED (GATIFLOXACIN + PREDNISOLONE ACETATE) EVERY 8 HOURS AND STER (PREDNISOLONE ACETATE) EVERY 8 HOURS FOR SEVEN DAYS. ON (B)(6), DURING A FOLLOW UP APPOINTMENT, THE DOCTOR CHANGED THE PRESCRIPTION TO ZYPRED ¿ SUSPENDED, STER ¿ FREQUENCY CHANGED TO EVERY 6 HOURS FOR SEVEN DAYS AND HYABAK LUBRICANT EVERY 6 HOURS WAS ADDED. THE PATIENT IS SUPPOSED TO INTERCALATE THE USE OF STER AND HYABAK AND RETURN FOR A FOLLOW-UP AFTER 7 DAYS.

  Patient problems: Corneal Edema; Eye Injury

  MAUDE report 7919737 ↗